肿瘤细胞治疗研究
ALL SOURCES
把在研试验和前沿论文合在一起看,按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和(导航里的「临床试验」板块只收在招的那部分,不另计入)。
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumors.
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。